Start your 7-day free trial — unlock full access instantly.

Lead Closed

This opportunity is no longer accepting submissions.

Lebanon (City)Green Risk

ClosedPublic Safety

NJ State Free and Anonymous Narcan Program

BID #: N/A

DUE: TBD

VALUE: TBD

100

Rating

Risk Rank

Green Risk

AI-Powered Lead Insights

Executive Summary

The New Jersey Pharmacy-based Initiative to Provide Naloxone Freely and Anonymously (Naloxone365) aims to eliminate cost and stigma barriers to acquiring naloxone. Participating pharmacies can offer naloxone for no charge and without identification, billing the state for reimbursement at the current Medicaid rate. The program is financed through federal grant dollars and allows any member of the public to receive a package of 2-dose, 4mg intranasal spray at participating pharmacies.

Web Content

Automated discovery link found on Lebanon (City) website.

Document Text

--- Document: NJ State Free and Anonymous Narcan Program Document ---
New Jersey’s Pharmacy-based Initiative to Provide Naloxone 
Freely and Anonymously
NALOXONE 365
Questions? Email us at Naloxone@dhs.nj.gov
Why is Naloxone365 important?
Despite issuing a standing order for naloxone in 2018, there remain cost and stigma barriers 
for individuals to acquire naloxone. Naloxone365 is designed to eliminate those barriers for 
consumers and allow for seamless billing by pharmacists. This program is a key component 
of New Jersey’s plan to saturate the state with this lifesaving medication.
Interested in participating? 
New Jersey pharmacies interested in participating must complete the Naloxone Pilot Program Agreement and submit 
the signed agreement to the NJ Board of Pharmacy MyLicense portal for approval. After receiving confirmation of 
participation via NJ BOP, pharmacies may offer naloxone for no charge and without identification. More information on 
the program logistics can be found in Medicaid Newsletter vol. 33, no. 1.
Pharmacies and Pharmacists?
Pharmacies 
that 
complete 
the 
Naloxone Pilot Program Agreement 
can bill for reimbursement of 4 
mg intranasal spray naloxone they 
distribute at the current Medicaid 
rate.
Policymakers?
Naloxone365 is a template to 
use existing and familiar billing 
mechanisms and federal funding 
to expand access to lifesaving 
medication through partnering with 
a trusted community care provider. 
State of New Jersey
Phil Murphy, Governor | Tahesha L. Way, Lt. Governor
N
J
 
s
t
ate seal
Department of Human Services 
Sarah Adelman, Commissioner
Opioid addiction and overdoses continue to impact communities throughout New Jersey and across the country at an 
alarming rate. Since 2018, tens of thousands of New Jerseyans have experienced an overdose and more than 15,000 
died of a suspected drug-related death. To combat and curb this epidemic, New Jersey has worked to bolster harm 
reduction efforts throughout the state including expanding the availability of naloxone through statewide distribution 
days. In 2023, New Jersey took the next steps to make naloxone readily available every day of the year for free.
In January 2023, Governor Murphy announced a nation-leading program to allow anyone 14 years or older to acquire 
naloxone anonymously and at no cost at participating pharmacies across New Jersey. The Department of Human 
Services partnered with the New Jersey Board of Pharmacy and its Medicaid division to craft and implement this 
unique program. Image of Narcan nasal spray
The Public?
Any member of the public can now 
enter a participating pharmacy and 
ask a pharmacist for naloxone. They 
will receive a package of 2 dose, 
4mg intranasal spray without need 
for identification or purchase.
What Does This Mean For...
How does Naloxone365 work? 
Pharmacies acquire naloxone through their normal network of medication distributors and after 
dispensing, bill the state utilizing a special NJMMIS/Medicaid billing code to receive reimbursement 
at the current Medicaid rate. The state is using federal grant dollars to finance this program.